As the world anxiously awaits a coronavirus vaccine, a Maryland biotechnology company already has signed deals to do initial production of three candidates. If one of them works, the firm has a factory in place to manufacture hundreds of millions of doses a year.
Emergent BioSolutions of Gaithersburg has long been preparing for a global disease outbreak. The firm got started making a vaccine against anthrax, and since then has produced candidates for the Ebola and Zika viruses.
Image: Luis M. Branco, PhD Managing Director and Co-Founder